The Centers for Medicare and Medicaid Services has put Part D drug plans on notice: starting in 2025, plans must offer an option that lets participating enrollees pay $0 cost sharing at the pharmacy counter for Part D-covered drugs, with those out-of-pocket costs billed later by the plan. The policy, called the Medicare Prescription Payment Plan, shifts out-of-pocket costs away from the point of sale and into predictable monthly bills sent by the plan itself. For seniors who have delayed filling expensive prescriptions because of sticker shock at the register, the change could reshape how they manage drug spending throughout the year.
How the $0 Pharmacy Counter Works
The mechanics are straightforward but represent a real departure from how most Medicare beneficiaries have paid for drugs. Under the new program, enrollees who opt in will owe $0 cost sharing when they pick up a Part D-covered prescription, and the plan bills that cost sharing later. Instead, their health or drug plan sends them a bill each month. As the official consumer page on Medicare.gov explains, participants “get a bill from your health or drug plan to pay for your prescription drugs (instead of paying the pharmacy).” There is no enrollment fee, no interest charge, and no cost to participate, which means the financial benefit comes from smoothing the timing of payments rather than reducing the total amount owed over the year.
The legal foundation for this requirement sits in federal regulation. Under 42 CFR 423.137, Part D sponsors must, for applicable plan years, provide enrollees the option to “pay $0 cost sharing at the point of sale” and instead pay cost sharing in capped monthly amounts. That regulatory language is binding, not optional. Every Part D plan operating in 2025, whether standalone or bundled inside a Medicare Advantage contract, must offer this payment structure to any enrollee who requests it, and plans must build systems to track each participant’s running balance and apply payments accurately throughout the year.
Who Benefits and Who Already Pays Nothing
The payment plan targets a specific gap in Medicare’s drug benefit. Seniors with high-cost medications, particularly specialty drugs or brand-name treatments in the deductible phase, often face hundreds or even thousands of dollars in upfront costs during the first months of the year. By spreading those charges across monthly installments, the program prevents a single pharmacy visit from consuming an outsized share of a retiree’s fixed income. CMS has described the program as intended to reduce the burden of out-of-pocket prescription drug costs, and the design reflects that goal directly by turning unpredictable spikes into a more budget-friendly schedule of bills.
A separate group of beneficiaries already pays nothing, or close to it, through a different channel. More than 14 million Medicare beneficiaries are eligible for Extra Help (the Part D Low-Income Subsidy), and CMS says many of these beneficiaries have access to $0 premium plan options, according to a CMS fact sheet on 2025 program stability. Extra Help, also known as the Low Income Subsidy, covers premiums and reduces cost sharing for qualifying low-income enrollees, effectively shielding them from the worst of high drug costs. The new payment plan is not a replacement for Extra Help. It is an additional layer aimed at the broader Part D population, including people whose incomes are too high for subsidy eligibility but who still struggle with large pharmacy bills early in the coverage year and may welcome a no-interest installment option.
What Monthly Billing Actually Looks Like
Opting into the payment plan does not erase drug costs. It restructures when and how those costs arrive. After a beneficiary fills a prescription and pays $0 at the counter, the plan calculates the enrollee’s share of the cost and adds it to a monthly statement. The total owed each month is capped, preventing a sudden spike if someone fills multiple prescriptions in a short window, and unpaid balances can carry forward within the calendar year as long as the person remains enrolled in the plan. CMS released guidance on the program in two stages, with Part One published on February 29, 2024, and a subsequent Part Two release, both accessible through the agency’s dedicated program hub that consolidates technical instructions for plans and high-level explanations for consumers.
Edge cases and billing disputes are a real concern for any system that moves payment away from the point of transaction. CMS addressed many of these scenarios in an updated FAQ document published in May 2025, covering questions about what happens when enrollees switch plans mid-year, how retroactive coverage adjustments affect monthly bills, and what protections exist against delayed or inaccurate charges. The FAQ signals that the agency is aware billing complexity could undermine trust in the program, particularly among seniors who are accustomed to paying at the pharmacy and may view a monthly statement with suspicion. It also underscores that plans must provide clear explanations of charges and offer processes to correct errors, reinforcing that beneficiaries retain the right to question and appeal amounts they believe are wrong.
The Trust Gap That Could Limit Enrollment
The biggest risk to the payment plan’s success may not be regulatory or administrative. It may be informational. CMS has not, in the materials linked above, published enrollment totals showing how many Part D enrollees have opted into the payment plan or released projected participation figures tied to a specific baseline scenario. Without that data, it is difficult to gauge whether the program is reaching the people who need it most or whether awareness remains low among seniors who do not regularly check federal Medicare resources. Beneficiaries who are already comfortable paying at the counter, or who distrust monthly billing from an insurer, may simply never opt in, especially if they fear that “$0 at the pharmacy” sounds too good to be true or might hide future surprises.
There is also a structural information gap between well-connected enrollees and those who lack reliable access to counseling or digital tools. Seniors who work with benefits counselors, use state health insurance assistance programs, or explore plan options through official channels are far more likely to learn about the payment plan than those who rely solely on mailed notices that can be dense or confusing. If enrollment skews toward already-informed beneficiaries, the program could widen the divide between seniors who actively manage their Medicare options and those who do not, rather than closing it. The design of the payment plan is sound on paper, but its real-world value depends on whether plans and pharmacies communicate the option clearly at the pharmacy counter, during customer service calls, and throughout the annual enrollment season.
What Seniors Should Weigh Before Opting In
The payment plan is not automatically applied. Enrollees must actively choose to participate, and they can do so at any point during the plan year, including after they learn they need a costly new medication. That flexibility is a strength, allowing someone diagnosed with a new condition mid-year to opt into monthly billing just as their prescriptions become more expensive. At the same time, seniors need to understand that once enrolled, they are responsible for paying the monthly statements in full and on time, even if they later stop filling the medication that triggered enrollment, because the plan is collecting what would otherwise have been paid at the pharmacy earlier in the year.
For many households, the key question is whether a steady bill is easier to handle than large, occasional charges. People with predictable monthly income, such as Social Security, may value the ability to align drug payments with their cash flow, while those who prefer to “pay as they go” might see little advantage. CMS has emphasized that overall Part D premiums are expected to remain relatively stable in 2025, pointing in a separate bid information release to efforts aimed at moderating premium growth even as new benefit features roll out. Against that backdrop, the prescription payment plan stands out as a structural change in how cost sharing is collected rather than a direct cut to prices. Seniors weighing the option should compare their current and expected drug spending, think through their comfort with monthly billing from their plan, and ask their pharmacy or plan representative to walk through concrete examples of how their payments would change over the course of the year.
More From The Daily Overview
*This article was researched with the help of AI, with human editors creating the final content.
Nathaniel Cross focuses on retirement planning, employer benefits, and long-term income security. His writing covers pensions, social programs, investment vehicles, and strategies designed to protect financial independence later in life. At The Daily Overview, Nathaniel provides practical insight to help readers plan with confidence and foresight.
